Is META stock still a buy?

Up more than 30% in 2024 is Meta Platforms (Meta Platforms Stock Quote, Chart, News, Analysts, Financials NASDAQ:META) still a buy?

Yes, says Roth MKM analyst Rohit Kulkarni, who in an update to clients April 23 reiterated his “Buy” rating and price target of $500.00 on META.

The analyst says META will have to come up big to keep the momentum going. The company’s first quarter results are due April 24, after the market close.

“META shares are +36% YTD vs. SPX +5%, after +194% in 2023 vs. S&P 500 +24%,” he noted. “In the past couple of weeks, shares are -8.5% vs. S&P -4%, implying overly ambitious buyside expectations have somewhat declined. Yet, we are marginally cautious heading into 1Q earnings as ’24 quarterly revenue cadence under tougher YoY comps, incremental growth drivers, and impact from European regulations are big unresolved debates among investors.”

Kulkarni thinks META will post EPS of $20.40 on revenue of $159.7-billion in fiscal 2024. He expects those numbers will improve to EPS of $22.19 on a topline of $174.5-billion in fiscal 2025.

The analyst says some of the top debates around META right now are whether or not it can beat the street with its first quarter results, what will drive incremental growth in 2024, and European regulations, which he describes as “an unknown risk that’s fairly tricky to put a framework around”.

“Our 12-month price target of $500 is based on 22.0x ’25E EPS (ex-Cash) and implies 22.5x GAAP P/E ’25E and 24.5x GAAP P/E ’24E,” the analyst concluded.

Tagged with: META
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

10 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

10 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

10 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

10 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

10 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

11 hours ago